pioglitazone has been researched along with Extravascular Hemolysis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koppireddi, S | 1 |
| Komsani, JR | 1 |
| Avula, S | 1 |
| Pombala, S | 1 |
| Vasamsetti, S | 1 |
| Kotamraju, S | 1 |
| Yadla, R | 1 |
1 other study available for pioglitazone and Extravascular Hemolysis
| Article | Year |
|---|---|
Novel 2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetamides as antioxidant and/or anti-inflammatory compounds.
Topics: Acetamides; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Drug Design; Erythrocytes; Free Radi | 2013 |